DRKS00013220进行中(未招募)不适用
Role of bowel ultrasonography to guide treatment with vedolizumab in patients with Crohn's disease and ulcerative colitis - VedoSono
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
- 入组人数
- 65
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 70 Years(—)
- 性别
- All
入选标准
- •Inclusion criteria for patients with active disease (study part 1):
- •1. Reliable diagnosis of Crohn's disease (active disease):
- •a. HBI = 7 and
- •b. Sonographic signs of active inflammation: intestinal wall thickness> 3.0 mm (colon) or> 2.0 mm (terminal ileum)
- •Reliable diagnosis of ulcerative colitis (active disease):
- •a. SCCAI = 5 and
- •b. Sonographic signs of active inflammation:
- •Intestinal wall thickness> 3.0 mm (Colon)
- •2. Study-independent therapy with vedolizumab
- •according to medical practice
- •3. Age 18 to 70 years
- •4. Sufficient communication skills in the German language
- •5. Patient must be able to recognize the nature, significance and scope of this study and to orientate its will accordingly
- •Inclusion criteria for patients in remission (study part 2):
- •1. Reliable diagnosis of Crohn's disease (remission): HBI = 4
- •Reliable diagnosis of ulcerative colitis (remission):
- •2. Study-independent therapy with vedolizumab
- •according to medical practice
- •3. Age 18 to 70 years
- •4. Sufficient communication skills in the German language
- •5. Patient must be able to recognize the nature, significance and scope of this study and to orientate its will accordingly
排除标准
- •1. Pregnancy or breastfeeding
- •2. Therapy with vedolizumab out of authorization
- •3. Contraindication to treatment with vedolizumab (sec.reg. FI)
- •4. Severe symptomatic strictures without signs of blood flow
- •5. Ileostoma or ileoanal pouch
- •6. Infectious colitis (e.g., Clostridium difficile colitis,
- •Cytomegalovirus colitis)
- •7. Obesity = grade I (BMI> 30) (insufficient, sonographic bowel wall imaging)
- •8. Ulcerative colitis: proctitis Crohn's disease: infestation of the upper GI tract (esophagus, stomach)
- •9. Participation in an intervention study within the last 30 days prior to initiation of therapy
- •10. Other medical reasons
研究者
相似试验
已完成
不适用
The efficacy of endoscopic ultrasonography-guided biliary drainage versus percutaneous transhepatic biliary drainage in patients with failed biliary cannulation of malignant biliary obstructionsDiseases of the digestive systemKCT0001370Asan Medical Center68
尚未招募
不适用
Examination of the usefulness of ultrasound-guided central venous catheterization.Patients scheduled for insertion of a central venous catheter.JPRN-UMIN000012930Asahikawa Medical University100
尚未招募
不适用
Role of stomach scanning to check the effect of different quantities of water on stomach emptying time in children posted for surgery.CTRI/2023/02/049561All India institute of medical sciences, jodhpur
已完成
不适用
The effectiveness of therapeutic ultrasound in the treatment of lumbar nerve root paiISRCTN54474269Department of Health30
已完成
2 期
ultrasonography new method to diagnose palatal expansioCTRI/2019/08/020685AIIMS New Delhi15
